Therapeutic Potential of Riboflavin, Niacin and Ascorbic Acid on Carbohydrate Metabolizing Enzymes in Secondary Endometrial Carcinoma Bearing Rats

Rose PG: Endometrial carcinoma. New Engl J Med 335: 640–649, 1996

Daniel Y, Inbar M, Bar-Am A, Renben Peyser MK, Lessing JB: The effects of tamoxifen treatment on the endometrium. Fertility and Sterility 65: 1083–1089, 1996

Han X, Liehr JG: Induction of covalent DNA adducts in Rodents by tamoxifen. Cancer Res 52: 1360–1363, 1992

Yager JD: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203–232, 1996

Murray M: Encyclopedia of nutritional supplements. Rocklin CA: Prima Publishing, 1996

Rivlin RS: In: Present knowledge in Nutrition: International Life Sciences Institute Press, Washington, DC, 1996, pp. 167–173

Garrison R, Somer E: The Nutrition desk reference. New Canaan, CT: Keats Publishing, 1995, pp. 133–140

Yan Q, Briehl M, Crowley CL, Payne CM, Bernstein H, Ernstein C: The NAD+ precursors, glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in jurkat cells. Biochem Biophys Res Commun 255: 133–136, 1999

Hageman GJ, Stierum RH: Niacin, Poly (ADP-ribose) Polymerase-1 and genomic stability. Mutat Res 475: 45–56, 2001

Jacobson EL, Shieh WM, Huang AC: Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Mol Cell Biochem 193: 69–74, 1999

Spronck JC, Kirkland JB: Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo. Mutat Res 508: 83–97, 2002

Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377–6381, 1989

Sharma M, Slocum HK: Prevention of quinone-mediated DNA arylation by antioxidants. Biochem Biophys Res Commun 262: 769–774, 1999

Liehr JG, Roy D, Gladek A: Mechanism of inhibition of estrogen induced renal carcinogenesis in male Syrian hamsters by vitamin C. Carcinogenesis (Lond.) 10: 1983–1988, 1989

Bendich A, Vitamin C: In: Vitamin C in health and disease: New York: Marcel Dekker Inc., 1997, pp. 367–379

Sujatha V, Muthumanickam V, Rani G, Sachdanandam P: Effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in experimentally induced mammary carcinoma in rats. J Pharm Pharmacol (Suppl) 51: 241, 1999

Hemminki K, Rajaniemi H, Lindahl B, Moberger B: Tamoxifen-induced DNA adducts in endometrial samples from Breast cancer patients. Cancer Res 56: 4374–4377, 1996

Dollery C: In: Therapeutic drugs: Harcourt Brace and Company Limited, Churchill Livingstone, 1999a, pp. R24–R25

Zempleni J, Galloway JR, McCormick DB: Pharmacokinetics of orally and intravenously administered riboflavin in healthy human. Am J Clin Nutr 63: 54–66, 1996

Dollery C: In: Therapeutic drugs: Harcourt Brace and Company Limited, Churchill Livingstone, 1999b, pp. N59–N61

Dipalma JR, Thayer WS: Use of niacin as a drug. Annu Rev Nutr 11: 169–187, 1991

Rader JI, Calvert RJ, Hathcock JN: Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med 92: 77–81, 1992

Vasavi H, Thangaraju M, Ramesh Babu J, Sachdanandam P: The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in Fibrosarcoma bearing rats. Cancer Biochem Biophys 16: 71–83, 1998

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–275, 1951

Fiske CH, Subbarow Y: The calorimetric determination of phosphorus. J Biol Chem 66: 375–400, 1925

Brandstrup N, Kirk JE, Bruni C: The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue inindividuals of various ages. J Gerontol 12: 166–171,1957

King J: In: Practical Clinical Enzymology: D. Van Nostrand: London, 1965a; pp. 121–138

Horrocks JE, Ward J, King J: A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol 16: 248–252, 1963

King J: In: Practical Clinical Enzymology: D.Van Nostrand: London, 1965b; pp. 191–208

Gancedo JM, Gancedo C: Fructose-1, 6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase in fermenting and nonfermenting yeast. Arch Microbiol 76: 132–138, 1971

Mazurek S, Boschek CB, Hugoc F, Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15: 300–308, 2005

Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson1 CB: ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311–321. 2005

Harada T, Nagasu M, Tsuboi I, Koshinaga M, Kanno H, Aizawa S: Cyclic polylactate inhibited growth of cloned leukemic cells through reducing glycolytic enzyme activities. Oncol Rep 14: 501–505. 2005

Simaga S, Osmak M, Babic D, Sprem M, Vukelic B, Abramic M: Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: Correlation with tumor grade. Int J Gynecol Cancer 15: 438–444, 2005

Chowdhury SKR, Gemin A, Singh G: High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun 333: 1139–1145, 2005

Arora KK, Pedersen PL: Functional significance of mitochondrial bound hexokinase in tumour cell metabolism. J Biol Chem 263: 17422–17428, 1988

Parry DM, Pedersen PL: Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumour. J Biol Chem 258: 10904–10912, 1983

Mathupale SP, Rempel A, Pedersen PL: Aberrant glycolytic metabolism of cancer cells: A remarkable co-ordination of genetic, transcriptional, post translational and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29: 339–343, 1997

Paul R, Iohansson R, Kellokumpu-Lehtinen PL, Soderstrom KV, Kangas L: Tumour localization with 18 F-2 Fluoro-2 deoxy D glucose: Comparative autoradiography, glucose-6-phosphatase histochemistry and histology of renally implanted sarcoma of the rat. Res Exp Med 185: 87–95, 1985

Graham MM, Spence AM, Muzi M, Abott GL: Deoxyglucose kinetics in a rat brain tumor. J Cereb Blood Flow Metab 9: 315–322, 1989

Hennipman A, Van Oirschot B, Smits J, Rijsken G, Staal GE: Heterogenicity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumour Biol 9: 178–189, 1988

Campbell DM, King EJ: Colorimetric determination of glucose in 20 microliters of blood. J Clin Pathol 16: 173–174, 1963

Parveen V, Sharma DC, Shastri KD: A clinico-biochemical study of phosphohexose-isomerase, aliesterate and sulphydryl group in 25 normal and 35 cancer patients. Ind J Cancer 43: 448–456, 1974

Weber G, Morris HP: Comparative biochemistry of hepatomas I carbohydrate enzymes in Morris hepatoma 5123. Cancer Res 21: 933–937, 1961

Weber G, Cantero A: Comparison of carbohydrate metabolism in normal and neoplastic liver enzyme studies. Acta Unio Int Contra Cancrum 16: 1002–1011, 1960